期刊文献+

供者特异性抗原诱导免疫耐受的实验研究 被引量:1

Study on Donor Specific Antigens in Inducing Immunogical Tolerance
下载PDF
导出
摘要 目的 比较不同特异性抗原和不同输注途径诱导免疫耐受的强度及探讨其可能机理。方法 建立大鼠颈部异位心脏移植模型 ,采用供体特异性全血、供体特异性脾细胞和骨髓细胞 (DSBM) ,通过外周、门静脉和胸腺三种不同途径输注以诱导免疫耐受的产生和维持。结果 供体特异性抗原诱导免疫耐受以 DSBM及通过胸腺接种途径效果最佳。结论 供者特异性抗原能诱导受体免疫耐受并促进移植物存活 ,可望成为较理想的临床免疫耐受诱导方法。 Objective To compare the effects of different donor specific antigens, through different pathways, on the inducement of immunological tolerance. Methods After the establishment of a stable rat cervical heterotopic heart transplantation model, donor specific transfusion (DST), donor specific spolenocyte (DSSL) and donor specific bone marrow (DSBM) were given to recipients 3 14 days prior to the transplantation through peripheral vein, portal vein and intrathymic injection respectiviely. Low dose CsA 5mg/(kg·d) was given from the 3rd 14th day pre transplantation to the 28th day post transplantation. The survival time of cardiac grafts was monitored, meanwhile, the donor specific mixed lymphocyte reaction (MLR) and the subsets of T lymphocytes CD 8 + were determined. Results DSBM and the administrative pathway of intrathymic injection achieved the best effects on the inducement of immunological tolerance and the improvement of graft survival. Conclusion The donor specific antigens can induce the donor specific immunological tolerance. It may be a practicable approach for the clinical experiments in the future.
出处 《华西医科大学学报》 CAS CSCD 北大核心 2001年第2期222-224,共3页 Journal of West China University of Medical Sciences
关键词 输血 脾细胞 骨髓细胞 免疫耐受 供者 特异性抗原 Whole blood Splenocyte Bone marrow Tolerance
  • 相关文献

参考文献5

二级参考文献1

共引文献5

同被引文献17

  • 1高思海,李平,潘铁成,杨辰垣.大鼠颈部异位心脏移植模型的改进[J].中国医师杂志,2004,6(11):1461-1462. 被引量:8
  • 2赵晓彬,晏晓明,杨松霖.Th1/Th2细胞因子mRNA的表达与角膜缘移植排斥的关系[J].眼科研究,2007,25(6):419-423. 被引量:5
  • 3WALDMANN H, GRACA L,COBBOLD S, et al. Regulatory T cells and organ transplantation[J]. Semin Immunol, 2004,16 :119-126.
  • 4KOSHIBA T, VAN DAMME B, KITADE HI, et al. Induction of tolerance by donor-specific blood transfusion in a model of intestinal transplantation: technical and immunological aspects[J]. Transplantation Proceedings, 2002, 34 (3) : 1033- 1039.
  • 5CHEN J, HE Q, ZHANG R, et aL Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival[J]. Clin Exp Immunol, 2004,138:245- 250.
  • 6MAYUMI H, SUGIURA K, INABA M, et al. A strategy for organ allografts without using immunosuppressants or irradiation[J]. Proc Natl Acad Sci USA, 1998,95(12):6947-6952.
  • 7STARZL T E, DEMETRIS A J, TRUCCO M, et al. Cell mi gration and chimerism after whole-organ transplantation: thebasis of graft acceptance[J]. Hepatology, 1993,17(6) : 1127- 1152.
  • 8YUNIS E J, ZUNIGA J, ROMERO V, et al. Chimerism and tetragametic chimerism in humans: implications in autoimmunity,allorecognition and tolerance[J]. Immunol Res, 2007,38 (13),213-236.
  • 9LI L, BOUSSIOTIS V A. Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences[J]. Chem Immunol Allergy, 2008,94 : 178-188.
  • 10MAGGI E, BIWAS D, PRETE G, et al. Accumulation of Th2-1ike helper T cells in the conjunctiva of patients with vernal conjunctivitis[J]. Immunol, 1991,146(4) : 1169-1174.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部